Myrbetriq ER 50 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DEV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,755
Award facts
- Contract value 100% obligated
- $52,754.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 6, 2026, provides MYRBETRIQ ER 50 mg tablets (90-count units) to the Defense Logistics Agency (DLA) through a firm fixed-price contract valued at $52,754.91. The award was made to AmerisourceBergen Drug Corp, the Corporate Office division of Cencora, Inc., with a place of performance in Conshohocken, Pennsylvania. The contract received no set-aside designation, indicating it was competitively awarded on a full and open basis. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The DLA Medical Supply Chain utilizes this IDC vehicle to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications for diabetes management, neurological conditions, pain management, and various other therapeutic domains. AmerisourceBergen's role as a critical pharmaceutical distributor enables it to fulfill federal procurement requirements across multiple therapeutic areas. The ultimate completion date for this delivery order is January 7, 2026, reflecting the standard short timeline typical of pharmaceutical supply deliveries under the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F6DEV?
SPE2DR26F6DEV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F6DEV worth?
The government has obligated $52,755 on SPE2DR26F6DEV.
Is contract SPE2DR26F6DEV an order under another contract?
Yes. SPE2DR26F6DEV is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DEV competed?
The extent of competition for SPE2DR26F6DEV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award